Skip to main content
COFCO BIOTECHNOLOGY CO., LTD. logo

COFCO BIOTECHNOLOGY CO., LTD. — Investor Relations & Filings

Ticker · 000930 ISIN · CNE000000ZR7 LEI · 300300CSR7RNP1P1CP32 Shenzhen Stock Exchange Manufacturing
Filings indexed 2,252 across all filing types
Latest filing 2023-08-25 Interim / Quarterly Rep…
Country CN China
Listing Shenzhen Stock Exchange 000930

About COFCO BIOTECHNOLOGY CO., LTD.

https://www.cofcotech.com

COFCO Biotechnology Co., Ltd. specializes in the deep processing of agricultural products, primarily corn, cassava, and other grains. The company operates as a major producer of fuel ethanol, edible alcohol, and starch-based products. Its portfolio includes a wide range of sweeteners such as fructose and glucose, as well as organic acids like citric acid and lactic acid. Additionally, the firm develops bio-based materials and biochemical products including amino acids and feed additives. Serving diverse sectors such as food and beverage, pharmaceuticals, and renewable energy, the company focuses on technological innovation in biotechnology to enhance resource efficiency and promote sustainable industrial applications. It maintains a significant presence in the global supply chain for bio-based chemicals and ingredients.

Recent filings

Filing Released Lang Actions
2023年半年度报告摘要
Interim / Quarterly Report Classification · 95% confidence The document is titled as a '2023 半年度报告摘要' which translates to '2023 Semi-Annual Report Summary'. It contains detailed financial data such as revenue, net profit, cash flow, earnings per share, and asset information for the half-year period. It also includes company basic information, shareholder data, and accounting policy changes. The document length is 2991 characters, which is relatively short but contains substantive financial data and analysis, not just an announcement or a link to a report. The content matches the characteristics of an Interim / Quarterly Report (IR) as it covers a period shorter than a full fiscal year with actual financial statements and analysis. Therefore, the correct classification is IR (Interim / Quarterly Report). H1 2023
2023-08-25 Chinese
半年报董事会决议公告
Board/Management Information Classification · 95% confidence The document is an announcement of resolutions passed at the company's eighth board meeting, including approval of the 2023 half-year report and other internal matters such as accounting policy changes and management bonuses. It does not contain the full half-year report itself but references that the report and related opinions are published elsewhere. The document is short (1140 characters) and serves as a formal board meeting resolution announcement rather than a full financial report. Therefore, it fits best under Board/Management Information (MANG) as it relates to board decisions and management matters.
2023-08-25 Chinese
半年度非经营性资金占用及其他关联资金往来情况汇总表
Management Reports Classification · 85% confidence The document is a detailed tabular summary of non-operating fund occupation and other related party fund transactions for the first half of 2023, prepared by a company named 中粮生物科技股份有限公司. It contains financial data such as balances, amounts, interest, and reasons for fund occupation or transactions, covering the period January to June 2023. The document is not a narrative report but a financial summary table with accounting details. It does not appear to be a full interim or quarterly report with comprehensive financial statements and analysis, nor is it an announcement or certification. The content is focused on related party transactions and fund occupation, which is typically part of management reports or disclosures related to financial results and business trends. Given the detailed financial data and the focus on management explanation of these transactions, the document best fits the category of Management Reports (MDA).
2023-08-25 Chinese
半年报监事会决议公告
Regulatory Filings Classification · 95% confidence The document is a formal announcement of the supervisory board meeting resolutions of 中粮生物科技股份有限公司. It details the attendance, voting results, and approval of the company's 2023 semi-annual report and its summary. The document does not contain the actual semi-annual report or detailed financial data but rather the supervisory board's review and approval of that report. The document length is short (937 characters), and it serves as an official announcement of the meeting's resolutions rather than the report itself. Therefore, it fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not contain full financial reports.
2023-08-25 Chinese
2023年半年度财务报告
Interim / Quarterly Report Classification · 100% confidence The document is titled as a "2023 年半年度财务报告" which translates to "2023 Semi-Annual Financial Report". It contains detailed financial statements including consolidated balance sheets, profit and loss statements, cash flow statements, and changes in equity for the half-year period ending June 30, 2023. The document explicitly states it is an unaudited semi-annual report. The length of the document is substantial (15,000 characters), and it contains actual financial data and analysis, not just an announcement or certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR), which is a comprehensive financial report for a period shorter than a full fiscal year containing substantive financial data and analysis. H1 2023
2023-08-25 Chinese
关于公司与中粮财务有限责任公司关联存、贷款等金融业务风险评估报告
Audit Report / Information Classification · 95% confidence The document is a detailed risk assessment report of a financial company affiliated with the listed company, including extensive information on internal controls, risk management, regulatory compliance, financial data as of June 30, 2023, and operational details. It is not a full annual or interim financial report but a specialized risk evaluation report. It does not fit the categories of Annual Report (10-K), Interim Report (IR), or Earnings Release (ER). It is not a simple announcement or certification but a substantive report on risk assessment and internal controls. The content aligns best with an Audit Report / Information (AR) category, which includes standalone audit reports, applied accounting principles, and results of internal or regulatory stress tests, excluding full annual reports. The document focuses on risk evaluation, internal controls, and regulatory compliance, which fits the AR category. Confidence is high due to the detailed nature and regulatory references. H1 2023
2023-08-25 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.